MY152475A - Fused ring compounds and use thereof - Google Patents

Fused ring compounds and use thereof

Info

Publication number: MY152475A
Authority: MY; Malaysia
Prior art keywords: fused ring; ring compounds; present; glucokinase activator; agent
Prior art date: 2008-04-10

Application number

Other languages

English (en)

Inventor

Yasuma Tsuneo

Takakura Nobuyuki

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-10

Filing date

2009-04-09

Publication date

2014-10-15

2009-04-09 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2014-10-15 Publication of MY152475A publication Critical patent/MY152475A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compositions Of Macromolecular Compounds (AREA)
Enzymes And Modification Thereof (AREA)

MYPI20104694 2008-04-10 2009-04-09 Fused ring compounds and use thereof MY152475A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2008102691		2008-04-10

Publications (1)

Publication Number	Publication Date
MY152475A true MY152475A (en)	2014-10-15

Family

ID=40671202

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI20104694 MY152475A (en)	2008-04-10	2009-04-09	Fused ring compounds and use thereof

Country Status (34)

Country	Link
US (1)	US8673942B2 (pl)
EP (1)	EP2276760B1 (pl)
JP (1)	JP5528348B2 (pl)
KR (1)	KR20110002472A (pl)
CN (1)	CN102056924B (pl)
AR (1)	AR073609A1 (pl)
AU (1)	AU2009234666B2 (pl)
BR (1)	BRPI0910912A2 (pl)
CA (1)	CA2720686A1 (pl)
CO (1)	CO6321240A2 (pl)
CR (1)	CR11730A (pl)
CY (1)	CY1115247T1 (pl)
DK (1)	DK2276760T3 (pl)
DO (1)	DOP2010000301A (pl)
EA (1)	EA019640B1 (pl)
EC (1)	ECSP10010602A (pl)
ES (1)	ES2476265T3 (pl)
GE (1)	GEP20135846B (pl)
HR (1)	HRP20140588T1 (pl)
IL (1)	IL208463A (pl)
MA (1)	MA32283B1 (pl)
ME (1)	ME01887B (pl)
MX (1)	MX2010011138A (pl)
MY (1)	MY152475A (pl)
NZ (1)	NZ588562A (pl)
PE (1)	PE20100734A1 (pl)
PL (1)	PL2276760T3 (pl)
PT (1)	PT2276760E (pl)
RS (1)	RS53378B (pl)
SI (1)	SI2276760T1 (pl)
UA (1)	UA104422C2 (pl)
UY (1)	UY32131A (pl)
WO (1)	WO2009125873A1 (pl)
ZA (1)	ZA201007682B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2371826A4 (en)	2008-12-29	2012-06-27	Takeda Pharmaceutical	NEW CONNECTION WITH CONDENSED RINGS AND ITS USE
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en)	2011-09-27	2013-04-04	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9719970B2 (en)	2012-11-30	2017-08-01	Waters Technologies Corporation	Methods and apparatus for the analysis of vitamin D metabolites
WO2014099578A1 (en) *	2012-12-17	2014-06-26	Merck Sharp & Dohme Corp.	Novel glucokinase activator compounds, compositions containing such compounds, and methods of treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992015301A1 (en)	1991-03-01	1992-09-17	H. Lundbeck A/S	Treatment of hypertension and peripheral vascular diseases
US6506901B2 (en)	2000-07-17	2003-01-14	Wyeth	Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonists
JPWO2003103648A1 (ja)	2002-06-05	2005-10-06	株式会社医薬分子設計研究所	糖尿病治療薬
EP1532980A1 (en)	2003-11-24	2005-05-25	Novo Nordisk A/S	N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
WO2006089397A1 (en)	2005-02-22	2006-08-31	Gemin X Biotechnologies Inc.	Methods for treating arthritis using triheterocyclic compounds
EP2308839B1 (en) *	2005-04-20	2017-03-01	Takeda Pharmaceutical Company Limited	Fused heterocyclic compounds
AU2006295645B2 (en)	2005-09-30	2011-09-29	Msd K.K.	2-heteroaryl-substituted indole derivative
US8410087B2 (en)	2006-10-19	2013-04-02	Takeda Pharmaceutical Company Limited	Indole compound
WO2009025478A1 (en)	2007-08-17	2009-02-26	Lg Life Sciences Ltd.	Indole and indazole compounds as an inhibitor of cellular necrosis
CN101896483B (zh) *	2007-12-20	2013-11-20	株式会社Lg生命科学	葡糖激酶激活剂和包含其作为活性成分的药物组合物
JP5188583B2 (ja) *	2008-01-04	2013-04-24	エルジー・ライフ・サイエンシーズ・リミテッド	細胞、組織及び臓器保存効果を有するインドール及びインダゾール誘導体
EP2371826A4 (en)	2008-12-29	2012-06-27	Takeda Pharmaceutical	NEW CONNECTION WITH CONDENSED RINGS AND ITS USE

2009
- 2009-04-09 AU AU2009234666A patent/AU2009234666B2/en not_active Ceased
- 2009-04-09 DK DK09730930.6T patent/DK2276760T3/da active
- 2009-04-09 NZ NZ588562A patent/NZ588562A/en not_active IP Right Cessation
- 2009-04-09 MY MYPI20104694 patent/MY152475A/en unknown
- 2009-04-09 BR BRPI0910912-9A patent/BRPI0910912A2/pt not_active IP Right Cessation
- 2009-04-09 CN CN200980121846.8A patent/CN102056924B/zh not_active Expired - Fee Related
- 2009-04-09 UA UAA201013332A patent/UA104422C2/uk unknown
- 2009-04-09 PL PL09730930T patent/PL2276760T3/pl unknown
- 2009-04-09 US US12/936,785 patent/US8673942B2/en not_active Expired - Fee Related
- 2009-04-09 EA EA201071180A patent/EA019640B1/ru not_active IP Right Cessation
- 2009-04-09 ME MEP-2014-66A patent/ME01887B/me unknown
- 2009-04-09 RS RS20140324A patent/RS53378B/sr unknown
- 2009-04-09 KR KR1020107025180A patent/KR20110002472A/ko not_active Withdrawn
- 2009-04-09 JP JP2010538248A patent/JP5528348B2/ja not_active Expired - Fee Related
- 2009-04-09 ES ES09730930.6T patent/ES2476265T3/es active Active
- 2009-04-09 WO PCT/JP2009/057625 patent/WO2009125873A1/en not_active Ceased
- 2009-04-09 MX MX2010011138A patent/MX2010011138A/es active IP Right Grant
- 2009-04-09 GE GEAP2009011998 patent/GEP20135846B/en unknown
- 2009-04-09 CA CA2720686A patent/CA2720686A1/en not_active Abandoned
- 2009-04-09 HR HRP20140588AT patent/HRP20140588T1/hr unknown
- 2009-04-09 EP EP09730930.6A patent/EP2276760B1/en active Active
- 2009-04-09 SI SI200930911T patent/SI2276760T1/sl unknown
- 2009-04-09 PT PT97309306T patent/PT2276760E/pt unknown
- 2009-09-18 AR ARP090103590A patent/AR073609A1/es unknown
- 2009-09-21 UY UY0001032131A patent/UY32131A/es not_active Application Discontinuation
- 2009-09-30 PE PE2009001166A patent/PE20100734A1/es not_active Application Discontinuation
2010
- 2010-10-04 IL IL208463A patent/IL208463A/en not_active IP Right Cessation
- 2010-10-08 DO DO2010000301A patent/DOP2010000301A/es unknown
- 2010-10-14 CR CR11730A patent/CR11730A/es unknown
- 2010-10-27 ZA ZA2010/07682A patent/ZA201007682B/en unknown
- 2010-11-01 MA MA33304A patent/MA32283B1/fr unknown
- 2010-11-10 EC EC2010010602A patent/ECSP10010602A/es unknown
- 2010-11-10 CO CO10140654A patent/CO6321240A2/es active IP Right Grant
2014
- 2014-07-02 CY CY20141100499T patent/CY1115247T1/el unknown

Also Published As

Publication number	Publication date
MA32283B1 (fr)	2011-05-02
CO6321240A2 (es)	2011-09-20
JP5528348B2 (ja)	2014-06-25
JP2011516403A (ja)	2011-05-26
EA019640B1 (ru)	2014-05-30
PE20100734A1 (es)	2010-11-18
UY32131A (es)	2010-11-30
PT2276760E (pt)	2014-05-28
AR073609A1 (es)	2010-11-17
EP2276760B1 (en)	2014-04-09
AU2009234666B2 (en)	2014-02-20
UA104422C2 (uk)	2014-02-10
ES2476265T3 (es)	2014-07-14
EA201071180A1 (ru)	2011-04-29
IL208463A0 (en)	2010-12-30
CY1115247T1 (el)	2017-01-04
DOP2010000301A (es)	2010-12-31
MX2010011138A (es)	2010-11-12
ZA201007682B (en)	2011-12-28
RS53378B (sr)	2014-10-31
AU2009234666A1 (en)	2009-10-15
US20110098297A1 (en)	2011-04-28
GEP20135846B (en)	2013-06-10
EP2276760A1 (en)	2011-01-26
HRP20140588T1 (hr)	2014-08-01
US8673942B2 (en)	2014-03-18
CA2720686A1 (en)	2009-10-15
KR20110002472A (ko)	2011-01-07
PL2276760T3 (pl)	2014-09-30
WO2009125873A1 (en)	2009-10-15
SI2276760T1 (sl)	2014-05-30
NZ588562A (en)	2012-07-27
IL208463A (en)	2015-07-30
CN102056924B (zh)	2014-05-21
DK2276760T3 (da)	2014-05-26
CR11730A (es)	2010-12-08
CN102056924A (zh)	2011-05-11
HK1152932A1 (en)	2012-03-16
ECSP10010602A (es)	2011-03-31
ME01887B (me)	2014-12-20
BRPI0910912A2 (pt)	2015-08-11

Publication	Publication Date	Title
TN2009000129A1 (en)	2010-10-18	Indole compound
MY152475A (en)	2014-10-15	Fused ring compounds and use thereof
MX2010009736A (es)	2010-09-30	Compuesto heterociclico.
MY154798A (en)	2015-07-31	Fused cyclic compounds
TN2012000152A1 (en)	2013-12-12	Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
MY149648A (en)	2013-09-30	Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
MX2010002419A (es)	2010-03-30	(ciclopropilfenil) feniloxamidas, metodo para su produccion y uso como un medicamento.
MX2011005934A (es)	2011-12-16	Compuestos organicos.
PH12013501099A1 (en)	2013-07-08	Bicyclic compound
MX2009000884A (es)	2009-06-05	Derivados de piridizinona.
TW200745067A (en)	2007-12-16	Novel compounds
MY161890A (en)	2017-05-15	Pyrazolylaminopyridines as inhibitors of fak
MX2011011854A (es)	2011-12-06	Dihidropirimidinonas para uso como inhibidores de la bace2.
SG179034A1 (en)	2012-04-27	2 -aminodihydro [1, 3] thiazines as bace 2 inhibitors for the treatment of diabetes
MY153915A (en)	2015-04-15	Organic compounds
MX2011011661A (es)	2011-11-18	Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
MX2010008460A (es)	2010-08-30	Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular.
GB0812642D0 (en)	2008-08-20	Compounds
MX2010009022A (es)	2010-09-07	Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
MX2010003440A (es)	2010-04-21	Compuesto inhibidor de glicogeno fosforilasa y composicion farmaceutica del mismo.
TW200738627A (en)	2007-10-16	Trialkylsilyl-indoles
JO2999B1 (ar)	2016-09-05	مركب ثلاثي حلقي و استخدامه الدوائي
MX2010003442A (es)	2010-04-21	Compuesto inhibidor de fosforilasa de glicogeno y composicion farmaceutica del mismo.
MX2012007253A (es)	2012-07-17	Derivados triciclicos y sus usos y composiciones farmaceuticas.
TN2010000450A1 (en)	2011-12-29	Fused ring compounds and use thereof